Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Marco Colleoni

机构:European Institute of Oncology · ORCID:0000-0002-5743-3013

发表论文 839 篇 · 总被引 47268 次 · h-index 102

代表论文

  • Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group (2025 · Cancer Treatment Reviews · 被引 14)
  • Breastfeeding After Hormone Receptor–Positive Breast Cancer: Results From the POSITIVE Trial (2025 · Journal of Clinical Oncology · 被引 5)
  • Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17) (2025 · Annals of Oncology · 被引 4)
  • Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial (2025 · The Breast · 被引 4)
  • Abstract RF1-02: Palbociclib plus letrozole versus weekly paclitaxel, both in combination w/ trastuzumab plus pertuzumab, as neoadjuvant treatment for patients w/ HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17) (2025 · Clinical Cancer Research · 被引 3)
  • Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study (2025 · The Breast · 被引 2)